Ave Maria Biotech, Inc. was conceived as a direct response to the global health vulnerabilities exposed by the COVID-19 outbreak.
The Company’s flagship device, the BD-500, offers real-time detection of airborne viruses and other pathogens, empowering businesses, healthcare facilities, the military, and public spaces to take immediate action, based on accurate data.
If a virus like COVID-19 enters a room, the BD-500 airborne virus detector will detect the threat in as little as 5 minutes.
The coronavirus pandemic ushered in unprecedented global health challenges and economic turmoil. Societal lockdowns and isolation measures took a toll not only on physical health but also on mental well-being and economic stability.
While symptomatic individuals are easily identifiable, silent spreaders and asymptomatic carriers remain a challenge, emphasizing the need for continuous monitoring.
Traditional detection methods, such as PCR tests, are critical but come with a time delay, hindering immediate responses and containment efforts.
Areas with high foot traffic, including airports, hospitals, and malls, are at increased risk due to the absence of continuous monitoring.
Beyond the immediate health implications, recurring outbreaks lead to further lockdowns, affecting economics and straining societal structures.
The BD-500 offers continuous monitoring of customer environments, ensuring immediate detection of potential threats. Unlike traditional methods, which are based on acquiring samples from symptomatic individuals and lab analysis, the BD-500 monitors the environment and provides actionable insights within minutes of a pathogen entering the space.
The BD-500 networked capabilities allow for synchronized monitoring across multiple devices. Each device feeds real-time data into a centralized portal, equipping administrators with a comprehensive, at a glance, overview of contagion levels across the entire monitored environment.
The concurrent monitoring of a distributed network of BD-500's alerts administrators to the specific unit detecting a threat. This level of granularity enables decision makers to implement precise, targeted interventions - addressing only the affected zones and allowing the rest to operate without unnecessary disruptions.
In scenarios like pandemics or outbreaks, maintaining operational continuity in critical sectors is vital. The BD-500 supports these sectors by delivering timely, actionable data on airborne threats, empowering organizations to enact preventive measures proactively and avert larger crises. For example, a hospital can swiftly isolate affected areas, ensuring the rest of the facility remains functional. Similarly, a military base can quarantine specific barracks without halting overall operations.
Considering the world spent an estimated $24 trillion in just the first year of responding to COVID, many companies and governments are now allocating significant budgets to be better prepared for future pandemics. The BD-500 directly addresses this growing, global need for proactive monitoring. As establishments worldwide increasingly recognize the value of real-time airborne virus detection, the demand for solutions like the BD-500 is significant.
Tedros Ghebreyesus, Director General of the World Health Org
With thousands of military housing and building types across the U.S. and world, Ave Maria Biotech aims to leverage its CRADA with the military to gain direct access to procurement channels. Our devices, strategically placed in high-traffic common areas (such as barracks, headquarters areas, etc), will serve as a frontline defense against biothreats, ensuring the health and readiness of our forces and the continuity of government operations in a potential biohazard situation.
Targeting 172 VA Medical Centers, 1,113 Community Based Outpatient Clinics, and 550 VA Convalescent Centers, Ave Maria Biotech plans to work closely with the Veterans Health Administration. We will engage in direct sales efforts to centralized procurement functions within the VA system. Our devices, placed in waiting rooms and operating rooms, will help to protect our nation’s veterans by providing real-time air quality monitoring and pathogen detection.
With a focus on the 44,500 seniors housing and assisted living facilities in the U.S., Ave Maria Biotech will engage with major healthcare networks and individual facility managers. We will also explore partnerships with healthcare distributors and Group Purchasing Organizations (GPOs) to streamline sales. Our devices, placed in common areas and patient rooms, will provide an added layer of protection for our most vulnerable population.
Targeting the global cruise industry, Ave Maria Biotech aims to negotiate a 2-year exclusivity agreement with one luxury cruise company. This agreement will position our company as the sole provider of biothreat detection devices for a major fleet. We will emphasize the device's ability to enhance passenger and crew safety and health, a critical factor for the cruise industry's continued revival. With multiple devices on each ship, strategically placed in key areas, out cruise industry partner will set a new gold standard in maritime health security.
The airline industry is a key focus area for controlling the global spread of airborne threats. Through air testing and its quick
response rate, the BD-500 offers significant benefits to current testing. These include the prompt detection of potential health threats, such as viruses or bacteria, and the implementation of targeted measures to contain and prevent their spread before anyone begins to show symptoms. The application of BD-500 in the airline industry enables the rapid and effective detection of potential health and safety threats, helping to reduce the risk of infection spread and ensuring high safety standards for all participants in the aviation process.
Livestock safety is a critical aspect of the food industry, and the BD-500 can significantly enhance security within food production, food processing and packaging facilities by continuously monitoring the environment for viral contaminants or other airborne threats. The application of BD-500 in ensuring food security helps secure the food supply for consumers. Ave Maria Biotech is in discussion with multiple companies in this space to establish partnerships for monitoring and gathering additional data on device performance in the diverse environments across the food supply continuum.